Hypertension Increases Retinal Inflammation in Experimental Diabetes: A Possible Mechanism for Aggravation of Diabetic Retinopathy by Hypertension

REFERENCES

• Fong D S, Aiello L, Gardner T W, et al. Diabetic retinopathy. Diabetes Care 2003; 26: S99–S102, (Suppl I)
   PubMed Web of Science ®Google Scholar
• Wan Nazaimoon W M, Letchuman R, Noraini N, et al. Systolic hypertension and duration of diabetes mellitus are important determinants of retinopathy and microalbuminuria in young diabetics. Diabetes Res Clin Pract. 1999; 46: 213–221
   PubMed Web of Science ®Google Scholar
• Agardh C D, Agardh E, Torffvit O. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5-year follow-up study of 442 adult patients in routine care. Diabetes Res Clin Pract. 1997; 35: 113–121
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications Trial Research Group. Clustering of Long-Term Complications in Families with Diabetes in the Diabetes Control and Complications Trial. Diabetes 1997; 46: 1829–1839
   PubMed Web of Science ®Google Scholar
• Lopes d e, Faria J M, Silveira L A, Morgano M, Pavin E J, Lopes de Faria J B. Erythrocyte sodium-lithium countertransport and proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2000; 41: 1482–1485
   PubMed Web of Science ®Google Scholar
• Haller H, Behrend M, Park J K, Schaberg T, Luft F C, Distler A. Monocyte infiltration and c-fms expression in hearts of spontaneously hypertensive rats. Hypertension 1995; 25: 132–138
   PubMed Web of Science ®Google Scholar
• Luft F C, Mervaala E, Muller D N, et al. Hypertension-induced end-organ damage: a new transgenic approach to an old problem. Hypertension. 1999; 33: 212–218
   PubMed Web of Science ®Google Scholar
• Wolf G, Ziyadeh F N, Thaiss F, et al. Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells: role of the angiotensin type 2 receptor. J Clin Invest 1997; 100: 1047–1058
   PubMed Web of Science ®Google Scholar
• Hilgers K F, Hartner A, Porst M, et al. Monocyte chemoattractant protein-1 and macrophage infiltration in hypertensive kidney injury. Kidney Int. 2000; 58: 2408–2424
   PubMed Web of Science ®Google Scholar
• Sabbatini M, Strocchi P, Vitaioli L, Amenta F. Changes of retinal neurons and glial fibrillary acid protein immunoreactive astrocytes in spontaneously hypertensive rats. J Hypertens 2001; 19: 1861–1869
   PubMed Web of Science ®Google Scholar
• McLeod D S, Lefer D J, Merges C, Lutty G A. Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol 1995; 147: 642–653
   PubMed Web of Science ®Google Scholar
• Miyamoto K, Khosrof S, Bursell S-E, et al. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci USA 1999; 96: 10836–10841
   PubMed Web of Science ®Google Scholar
• Barouch F C, Miyamoto K, Allport J R, et al. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Invest Ophthalmol Vis Sci. 2000; 41: 1153–1158
   PubMed Web of Science ®Google Scholar
• Joussen A M, Murata T, Tsujikawa A, Kirchhof B, Bursell S E, Adamis A P. Leukocyte-Mediated Endothelial Cell Injury and Death in the Diabetic Retina. Am J Pathol 2001; 158: 147–152
   PubMed Web of Science ®Google Scholar
• Lee S J, Benveniste E N. Adhesion molecule expression and regulation on cells of the central nervous system. J Neuroimmunol 1999; 98: 77–88
   PubMed Web of Science ®Google Scholar
• Streit W J, Mrak R E, Griffin W S. Microglia and neuroinflammation: a pathological perspective. J Neuroinflammation 2004; 1: 14
   PubMed Web of Science ®Google Scholar
• Beckman J S, Chen J, Crow J P, Ye Y Z. Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeneration. Prog Brain Res. 1994; 103: 371–380
   PubMed Web of Science ®Google Scholar
• Chao C C, Hu S, Ehrlich L, Peterson P K. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav Immun. 1995; 9: 355–365
   PubMed Web of Science ®Google Scholar
• Chao C C, Hu S, Peterson P K. Modulation of human microglial cell superoxide production by cytokines. J Leukoc Biol. 1995; 58: 65–70
   PubMed Web of Science ®Google Scholar
• Chao C C, Hu S, Sheng W S, Bu D, Bukrinsky M I, Peterson P K. Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism. Glia. 1996; 16: 276–284
   PubMed Web of Science ®Google Scholar
• Bolaños J P, Almeida A, Fernandez E, et al. Potential mechanisms for nitric oxide-mediated impairment of brain mitochondrial energy metabolism. Biochem Soc Trans. 1997; 25: 944–949
   PubMed Web of Science ®Google Scholar
• Loihl A K, Murphy S. Expression of nitric oxide synthase-2 in glia associated with CNS pathology. Prog Brain Res. 1998; 118: 253–267
   PubMed Web of Science ®Google Scholar
• Bal-Price A, Brown G C. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci. 2001; 21: 6480–6491
   PubMed Web of Science ®Google Scholar
• Funatsu H, Yamashita H, Noma H, Mimura T, Yamashita T, Hori S. Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema. Am J Ophthalmol 2002; 133: 70–77
   PubMed Web of Science ®Google Scholar
• Dijkstra C D, Dopp E A, Joling P, Kraal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology. 1985; 54: 589–599
   PubMed Web of Science ®Google Scholar
• North M J. Proteolytic Enzymes–A Practical Approach, P K Beynon, J S Bond. IRL Press, Oxford 1969; 117–119
   Google Scholar
• Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem. 1976; 72: 248–254
   PubMed Web of Science ®Google Scholar
• Okamoto K, Tabei R, Fukushima M, Nosaka S, Yamori Y. Further observations of the development of a strain of spontaneously hypertensive rats. Jpn Circ J 1966; 30: 703–716
   PubMedGoogle Scholar
• The UKPDS Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. Br Med J 1998; 317: 703–713
   PubMed Web of Science ®Google Scholar
• Porta M, Grosso A, Veglio F. Hypertensive retinopathy: there's more than meets the eye. J Hypertens 2005; 23: 683–696
   PubMed Web of Science ®Google Scholar
• Wong T Y, Klein R, Sharrett A R, et al. Atherosclerosis Risk in Communities Study. Retinal arteriolar diameter and risk for hypertension. Ann Intern Med. 2004; 140: 248–255
   PubMed Web of Science ®Google Scholar
• Conlan M G, Folsom A R, Finch A, et al. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost. 1993; 70: 380–385
   PubMed Web of Science ®Google Scholar
• Gabay G, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999; 340: 448–454
   PubMed Web of Science ®Google Scholar
• Sharrett A R, Hubbard L D, Cooper L S, et al. Retinal arteriolar diameters and elevated blood pressure: The Atherosclerosis Risk in Communities Study. Am J Epidemiol. 1999; 150: 263–270
   PubMed Web of Science ®Google Scholar
• Duncan B B, Wong T Y, Tyroler H A, Davis C E, Fuchs F D. Hypertensive retinopathy and incident coronary heart disease in high risk men. Br J Ophthalmol. 2002; 86: 1002–1006
   PubMed Web of Science ®Google Scholar
• Karalliedde J, Viberti G. Evidence for renoprotection by blockade of the renin-angiotensin-aldosterone system in hypertension and diabetes. J Hum Hypertens 2006; 20: 239–253
   PubMed Web of Science ®Google Scholar
• Wilkinson-Berka J L. Angiotensin and diabetic retinopathy. Int J Biochem Cell Biol 2006; 38: 752–765
   PubMed Web of Science ®Google Scholar
• Cheng Z J, Vapaatalo H, Mervaala E. Angiotensin II and vascular inflammation. Med Sci Monit 2005; 11: RA194–205
   PubMed Web of Science ®Google Scholar
• Ogden T E. Glia. Retina, J R Stephen. Elsevier: Mosby Inc. 1994; 54–57
   Google Scholar
• Akiyama H, McGeer P L. Brain microglia constitutively express-2 integrins. J Neuroimmunol 1990; 30: 81–93
   PubMed Web of Science ®Google Scholar
• Babcock A A, Kuziel W A, Rivest S, Owens T. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J Neurosci. 2003; 23: 7922–7930
   PubMed Web of Science ®Google Scholar
• Basu A, Krady J K, Levison S W. Interleukin-1: a master regulator of neuroinflammation. J Neurosci Res. 2004; 78: 151–156
   PubMed Web of Science ®Google Scholar
• Cowell R M, Xu H, Galasso J M, Silverstein F S. Hypoxic-ischemic injury induces macrophage inflammatory protein-1 expression in immature rat brain. Stroke. 2002; 33: 795–801
   PubMed Web of Science ®Google Scholar
• Engel S, Schluesener H, Mittelbronn M, et al. Dynamics of microglial activation after human traumatic brain injury are revealed by delayed expression of macrophage-related proteins MRP8 and MRP14. Acta Neuropathol (Berl). 2000; 100: 313–322
   PubMed Web of Science ®Google Scholar
• Hailer N P, Bechmann I, Heizmann S, Nitsch R. Adhesion molecule expression on phagocytic microglial cells following anterograde degeneration of perforant path axons. Hippocampus. 1997; 7: 341–349
   PubMed Web of Science ®Google Scholar
• Milner R, Campbell I L. The extracellular matrix and cytokines regulate microglial integrin expression and activation. J Immunol. 2003; 170: 3850–3858
   PubMed Web of Science ®Google Scholar
• Olson J K, Miller S D. Microglia initiate CNS innate and adaptive immune responses through multiple TLRs. J Immunol. 2004; 173: 3916–3924
   PubMed Web of Science ®Google Scholar
• Sawada M, Kondo N, Suzumura A, Marunouchi T. Production of tumor necrosis factor- by microglia and astrocytes in culture. Brain Res. 1989; 491: 394–397
   PubMed Web of Science ®Google Scholar
• Takanohashi A, Yabe T, Schwartz J P. Pigment epithelium-derived factor induces the production of chemokines by rat microglia. Glia. 2005; 51: 266–278
   PubMed Web of Science ®Google Scholar
• Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol. 2003; 21: 335–376
   PubMed Web of Science ®Google Scholar
• Wang J Y, Shum A Y, Chao C C, Kuo J S, Wang J Y. Production of macrophage inflammatory protein-2 following hypoxia/reoxygenation in glial cells. Glia. 2000; 32: 155–164
   PubMed Web of Science ®Google Scholar
• Woodroofe M N, Sarna G S, Wadhwa M, et al. Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: Evidence of a role for microglia in cytokine production. J Neuroimmunol. 1991; 33: 227–236
   PubMed Web of Science ®Google Scholar
• Chew L J, Takanohashi A, Bell M. Microglia and inflammation: Impact on developmental brain injuries. Ment Retard Dev Disabil Res Rev. 2006; 12: 105–112
   PubMedGoogle Scholar
• Rungger-Brandle E, Dosso A A, Leuenberger P M. Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci 2000; 41: 1971–1980
   PubMed Web of Science ®Google Scholar